Emcure Pharmaceuticals Ltd.
EMCURE
Classifica tra le azioni
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Prezzo delle azioni
$19.00
Capitalizzazione di mercato
$3.60B
Variazione (1 giorno)
-2.14%
Variazione (1 anno)
20.12%
Paese
IN
Scambia Emcure Pharmaceuticals Ltd. (EMCURE)
Categoria
Healthcare
Storico del rendimento da dividendi per Emcure Pharmaceuticals Ltd. (EMCURE)
Il rendimento da dividendi (TTM) di Emcure Pharmaceuticals Ltd. (simbolo azionario: EMCURE) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Emcure Pharmaceuticals Ltd. (EMCURE) da 2025 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2025 | 0.00% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
